Related Experiment Video
Updated: Jul 8, 2025
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
Harnessing immunotherapy for brain metastases: insights into tumor-brain microenvironment interactions and emerging
Dairan Zhou1, Zhenyu Gong2, Dejun Wu3
1Department of Neurosurgery, Changzheng Hospital, Naval Medical University, 415 Fengyang Road, Huangpu District, Shanghai, 200003, People's Republic of China.
Abstract:
Brain metastases signify a deleterious milestone in the progression of several advanced cancers, predominantly originating from lung, breast and melanoma malignancies, with a median survival timeframe nearing six months. Existing therapeutic regimens yield suboptimal outcomes; however, burgeoning insights into the tumor microenvironment, particularly the immunosuppressive milieu engendered by tumor-brain interplay, posit immunotherapy as a promising avenue for ameliorating brain metastases. In this review, we meticulously delineate the research advancements concerning the microenvironment of brain metastases, striving to elucidate the panorama of their onset and evolution. We encapsulate three emergent immunotherapeutic strategies, namely immune checkpoint inhibition, chimeric antigen receptor (CAR) T cell transplantation and glial cell-targeted immunoenhancement. We underscore the imperative of aligning immunotherapy development with in-depth understanding of the tumor microenvironment and engendering innovative delivery platforms. Moreover, the integration with established or avant-garde physical methodologies and localized applications warrants consideration in the prevailing therapeutic schema.
Insights
Immunotherapy offers new hope for treating brain metastases from advanced cancers like lung, breast, and melanoma. Understanding the tumor microenvironment is key to developing effective immune treatments for these challenging conditions.
Area of Science:
- Oncology
- Immunology
- Neuroscience
Background:
- Brain metastases are a severe complication of advanced cancers, significantly reducing patient survival.
- Current treatments for brain metastases have limited efficacy.
- The tumor microenvironment in the brain plays a crucial role in cancer progression and immune evasion.
Purpose of the Study:
- To review recent advancements in understanding the brain metastatic tumor microenvironment.
- To explore emerging immunotherapeutic strategies for treating brain metastases.
- To highlight the importance of integrating immunotherapy with novel delivery platforms and physical methods.
Main Methods:
- Literature review of research on brain metastases and their microenvironment.
- Analysis of current and emerging immunotherapeutic approaches.
- Discussion of challenges and future directions in treating brain metastases.
Main Results:
- The immunosuppressive nature of the brain tumor microenvironment hinders effective treatment.
- Immune checkpoint inhibition, CAR T cell therapy, and glial cell-targeted immunoenhancement show promise.
- Innovative delivery platforms and combination therapies are crucial for success.
Conclusions:
- Harnessing immunotherapy, informed by a deep understanding of the brain tumor microenvironment, is a promising strategy.
- Developing targeted delivery systems and integrating immunotherapy with physical modalities are essential for improving outcomes.
- Further research into the tumor microenvironment is critical for advancing brain metastases treatment.
Related Concept Videos
01:27Tumor Immunotherapy
02:17The Tumor Microenvironment